Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

N Levitan; A Dowlati; D Shina; M Craffey; W Mackay; R DeVore; J Jett; S C Remick; A Chang; D Johnson

doi:10.1200/JCO.2000.18.5.1102

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

Identifier:nobleid.org/w1/20260515/062EC8C9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/062EC8C9.svg?ark=w1%2F20260515%2F062EC8C9)](https://nobleid.org/work/w1/20260515/062EC8C9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

Identifier:nobleid.org/w1/20260515/062EC8C9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/062EC8C9.svg?ark=w1%2F20260515%2F062EC8C9)](https://nobleid.org/work/w1/20260515/062EC8C9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work